Skip to content

Gross margin at other companies

Emergent Biosolutions logo
Emergent BiosolutionsEBS
54.2%+19.0pp
Opko Health logo
Opko HealthOPK
36%+4.2pp
Merck & Co. logo
Merck & Co.MRK
73.9%-2.5pp

Other financials

Income statement

See full
Revenue$6.2M-11.3%
Gross profit$3.3M-52.0%
Operating income-$5.3M-136%
Net income-$3.5M-746%
EPS (diluted)-$0.05-400%

Balance sheet

See full
Cash & equivalents$145.6M-10.3%
Total debt$601.0K-50.6%
Total equity$151.6M-29.8%
Total assets$219.4M-11.2%

Cash flow

See full
Operating cash flow-$8.7M-223%
CapEx--100%
Free cash flow-$8.7M-223%

Valuation

See full
Market cap$261.08M-44.3%
Enterprise value$116.11M-59.6%
P/E10.3×+3.8×
P/S2.8×+0.2×

Profitability

See full
Operating margin52.4%-7.8pp
Net margin43.2%-6.1pp
FCF margin66.2%

Returns & leverage

See full
Return on equity39.9%-18.5pp
Debt / equity0.0×
Current ratio3.2×-5.2×

Where this comes from

Calculated from SIGA Technologies’s reported figures.

Based on trailing twelve months.

The official record: SIGA Technologies’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about SIGA Technologies's gross margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SIGA Technologies's gross margin?
SIGA Technologies (SIGA) reported gross margin of 65.4% in Q1 2026.
How has SIGA Technologies's gross margin changed year-over-year?
SIGA Technologies's gross margin decreased by 14.6% year-over-year, from 76.5% to 65.4%.
What is the long-term trend for SIGA Technologies's gross margin?
Over 5 years (2020 to 2025), SIGA Technologies's gross margin has grown at a -4.9% compound annual growth rate (CAGR), from 88.2% to 68.6%.
What does gross margin mean?
Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.